Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhotics

doi:10.3748/wjg.v11.i28.4344

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2204)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

157

HTML

1781

Figures (1-3)

158

Tables (1-2)

108

Sum=2204

Jul 28, 2005 (publication date) through May 2, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Jul 28, 2005; 11(28): 4344-4350
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4344

Full Size Figure Download Figure

Figure 2 (PDF) ALT of Group IA and IB. A: ALT of Group IA: non cirrhotic patients with normal pre-treatment ALT (n = 13);B: ALT of Group IB: non-cirrhotic patients with elevated pre-treatment ALT (n = 12).

Citation: Dan YY, Wai CT, Lee YM, Sutedja DS, Seet BL, Lim SG. Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhotics. World J Gastroenterol 2005; 11(28): 4344-4350
URL: https://www.wjgnet.com/1007-9327/full/v11/i28/4344.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i28.4344